Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients

NCT06025240 is registered in ClinicalTrials.gov with Liverpool University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT06025240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06025240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Lead sponsor
Liverpool University Hospitals NHS Foundation Trust
Phase
Observational
Overall status
Recruiting
Start date
October 13, 2023
Completion date
October 13, 2026
Enrollment
282 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diagnosis, frailty, kidney transplant, kidney transplant rejection, kidney transplant; complications, renal transplant, renal transplant failure, transplant dysfunction